Clinical Trial Update: HF2 Therapy in the Treatment of Active Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for HF2 therapy in active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HF2 therapy

Snippet

Sponsor: Sheba Medical Center | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED